FDG PET and MRI Findings in a Case of Bing-Neel Syndrome.
Fiche publication
Date publication
avril 2018
Journal
Clinical nuclear medicine
Auteurs
Membres identifiés du Cancéropôle Est :
Pr NAMER Izzie-Jacques, Dr LHERMITTE Benoît, Pr DE SEZE Jérôme
Tous les auteurs :
Bund C, Lhermitte B, De Seze J, Kremer S, Namer IJ
Lien Pubmed
Résumé
A 64-year-old man was admitted for expressive aphasia with lack of words. He had been diagnosed with Waldenström 4 years before. At that time, he received 6 cycles of single-agent fludarabine, and remission was obtained. Because of acute expressive aphasia, he underwent brain MRI, which showed frontoparietal and insular subcortical gadolinium enhancement; Bing-Neel syndrome was suspected. Fronto-temporo-insular hypometabolism and left parietal hypometabolism were highlighted on FDG PET/CT. Structural and functional brain imaging revealed impairment of brain areas due to white matter changes and reinforced the diagnosis.
Mots clés
Brain, diagnostic imaging, Fluorodeoxyglucose F18, Humans, Magnetic Resonance Imaging, Male, Middle Aged, Nervous System Diseases, diagnostic imaging, Positron Emission Tomography Computed Tomography, Vidarabine, analogs & derivatives
Référence
Clin Nucl Med. 2018 Apr;43(4):262-264